Medical Devices
Researcher developing device similar to pregnancy test; blood or urine is placed on plastic sheet or in a cassette that shows results.
Lawmakers are imploring Mylan Pharmaceutical, the manufacturer of EpiPens, to scale back price increases that have seen the cost of the life-saving emergency allergy treatment swell from $100 to $600 per package, according to published reports.
University Hospitals in Cleveland recently became the first institution in Ohio to treat a patient using proton therapy. Their patient, a 24-year-old woman with rhabdomyosarcoma, was the first in the state to receive such care.
After two dozen infections were reported in French and Dutch hospitals, the company alerted European customers in January 2013 that a scope it manufactured could become contaminated.
This prototype machine produces 1,000 pills in 24 hours, faster than it can take to produce some batches in a factory. Allan Myerson, a professor of chemical engineering at MIT and a leader of the effort, says it could become eventually an option for anyone who makes medications, which typically require a lengthy and complex process of crystallization.
Alerts Tracker, which augments its Automatch platform, automatically identifies equipment models and supplies within a healthcare facility's inventory that are impacted by an alert or recall, and notifies designated department staff.
Beaumont Hospital in Royal Oak, Michigan is poised to become the latest proton therapy center in the United States having recently scored a Proteus One Gantry system that precisely directs cancer-killing proton beams at tumors.
U.S. manufacturers of medical devices started 2016 with a windfall -- a two-year suspension of a controversial tax on their revenue.
As part of the development of four new operating rooms, the University of Michigan Health System announced Monday that it will become one of the first hospitals in the country to integrate new neurosurgical imaging equipment called BrightMatter.
Members of Congress, federal officials and health-policy experts agree that the Food and Drug Administration's surveillance system for devices is inadequate and relies too heavily on manufacturers to report problems with their own products.